1. Home
  2. BAX vs TECH Comparison

BAX vs TECH Comparison

Compare BAX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baxter International Inc.

BAX

Baxter International Inc.

N/A

Current Price

$17.96

Market Cap

10.2B

Sector

Health Care

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$51.40

Market Cap

10.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAX
TECH
Founded
1931
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
10.2B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
BAX
TECH
Price
$17.96
$51.40
Analyst Decision
Hold
Strong Buy
Analyst Count
9
12
Target Price
$22.13
$73.09
AVG Volume (30 Days)
9.4M
2.1M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
0.22%
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$11,244,000,000.00
$1,219,635,000.00
Revenue This Year
$1.90
$2.49
Revenue Next Year
$2.09
$6.40
P/E Ratio
N/A
$109.66
Revenue Growth
5.72
5.23
52 Week Low
$17.07
$46.02
52 Week High
$35.03
$72.16

Technical Indicators

Market Signals
Indicator
BAX
TECH
Relative Strength Index (RSI) 37.42 32.09
Support Level $17.69 $48.93
Resistance Level $19.31 $54.08
Average True Range (ATR) 0.72 2.46
MACD -0.29 -0.38
Stochastic Oscillator 17.89 20.31

Price Performance

Historical Comparison
BAX
TECH

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: